Diabetes drug tested to protect hearts after attack
NCT ID NCT05050500
Summary
This study tested whether adding the diabetes drug dapagliflozin improves recovery and prevents future heart problems in people with type 2 diabetes who recently had a heart attack. It involved 143 participants who received either the drug or a placebo. Researchers measured future heart events, heart failure rates, and markers of inflammation to see if the drug provided protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mengmei Li
Qingdao, Shandong, 266042, China
Conditions
Explore the condition pages connected to this study.